BridgeBio Pharma financial statements

브리지바이오 파머NASDAQ:BBIO · Nasdaq · Healthcare · sector #17
$66.50-0.69%
2026-10-07 close · prelim

BridgeBio Pharma's published financial data is dated 2026-10-04. 2024 revenue was $222M. 2024 operating profit was −$441M.

Reported results

BridgeBio Pharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy